1. Home
  2. PYXS vs MATH Comparison

PYXS vs MATH Comparison

Compare PYXS & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • MATH
  • Stock Information
  • Founded
  • PYXS 2018
  • MATH 2015
  • Country
  • PYXS United States
  • MATH Hong Kong
  • Employees
  • PYXS N/A
  • MATH N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • MATH Finance/Investors Services
  • Sector
  • PYXS Health Care
  • MATH Finance
  • Exchange
  • PYXS Nasdaq
  • MATH Nasdaq
  • Market Cap
  • PYXS 75.0M
  • MATH 60.8M
  • IPO Year
  • PYXS 2021
  • MATH N/A
  • Fundamental
  • Price
  • PYXS $1.14
  • MATH $3.60
  • Analyst Decision
  • PYXS Strong Buy
  • MATH
  • Analyst Count
  • PYXS 5
  • MATH 0
  • Target Price
  • PYXS $9.00
  • MATH N/A
  • AVG Volume (30 Days)
  • PYXS 706.6K
  • MATH 197.9K
  • Earning Date
  • PYXS 08-13-2025
  • MATH 08-26-2025
  • Dividend Yield
  • PYXS N/A
  • MATH N/A
  • EPS Growth
  • PYXS N/A
  • MATH N/A
  • EPS
  • PYXS N/A
  • MATH 0.17
  • Revenue
  • PYXS N/A
  • MATH $31,399,049.00
  • Revenue This Year
  • PYXS N/A
  • MATH N/A
  • Revenue Next Year
  • PYXS N/A
  • MATH N/A
  • P/E Ratio
  • PYXS N/A
  • MATH $22.72
  • Revenue Growth
  • PYXS N/A
  • MATH 291.58
  • 52 Week Low
  • PYXS $0.83
  • MATH $0.80
  • 52 Week High
  • PYXS $5.39
  • MATH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 51.02
  • MATH 61.32
  • Support Level
  • PYXS $1.04
  • MATH $3.55
  • Resistance Level
  • PYXS $1.24
  • MATH $3.97
  • Average True Range (ATR)
  • PYXS 0.08
  • MATH 0.32
  • MACD
  • PYXS -0.00
  • MATH 0.03
  • Stochastic Oscillator
  • PYXS 53.57
  • MATH 83.49

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

Share on Social Networks: